• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于定义针对 HIV 的分层血清中和效力的单一、连续指标。

A single, continuous metric to define tiered serum neutralization potency against HIV.

机构信息

Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, United States.

New Mexico Consortium, Los Alamos, United States.

出版信息

Elife. 2018 Jan 19;7:e31805. doi: 10.7554/eLife.31805.

DOI:10.7554/eLife.31805
PMID:29350181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788501/
Abstract

HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most circulating viruses are tier 2, vaccines that elicit neutralization responses against them are needed. While tier classification is widely used for viruses, a way to rate serum or antibody neutralization responses in comparable terms is needed. Logistic regression of neutralization outcomes summarizes serum or antibody potency on a continuous, tier-like scale. It also tests significance of the neutralization score, to indicate cases where serum response does not depend on virus tiers. The method can standardize results from different virus panels, and could lead to high-throughput assays, which evaluate a single serum dilution, rather than a dilution series, for more efficient use of limited resources to screen samples from vaccinees.

摘要

HIV-1 包膜 (Env) 变体根据其中和敏感性表型分为不同的等级。这有助于认识到,第 1 级中和反应很容易被引发,但不能预防新的感染。第 3 级病毒对中和作用最不敏感。由于大多数循环病毒属于第 2 级,因此需要能够引发针对它们的中和反应的疫苗。虽然分层分类被广泛用于病毒,但需要一种能够以可比的方式评估血清或抗体中和反应的方法。中和结果的逻辑回归将血清或抗体效力概括为连续的、类似于分层的尺度。它还测试中和评分的显著性,以指示血清反应不依赖于病毒分层的情况。该方法可以标准化来自不同病毒面板的结果,并可能导致高通量测定,评估单个血清稀释度,而不是稀释系列,以更有效地利用有限的资源来筛选疫苗接种者的样本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/9e6037a714fe/elife-31805-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/2cc629aa3a8c/elife-31805-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/60c7c7e9e72b/elife-31805-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/61b10577d6cb/elife-31805-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/205657b99627/elife-31805-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/e268f76473f8/elife-31805-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/6af66e995caf/elife-31805-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/c9f97dd4e106/elife-31805-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/e5cdaf99c8e9/elife-31805-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/77eeecc6ce16/elife-31805-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/9e6037a714fe/elife-31805-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/2cc629aa3a8c/elife-31805-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/60c7c7e9e72b/elife-31805-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/61b10577d6cb/elife-31805-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/205657b99627/elife-31805-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/e268f76473f8/elife-31805-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/6af66e995caf/elife-31805-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/c9f97dd4e106/elife-31805-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/e5cdaf99c8e9/elife-31805-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/77eeecc6ce16/elife-31805-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a542/5788501/9e6037a714fe/elife-31805-fig6.jpg

相似文献

1
A single, continuous metric to define tiered serum neutralization potency against HIV.一种用于定义针对 HIV 的分层血清中和效力的单一、连续指标。
Elife. 2018 Jan 19;7:e31805. doi: 10.7554/eLife.31805.
2
Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals.来源于新近感染人类免疫缺陷病毒 1 型的泰国个体的血清的中和广度和效力。
Microbes Infect. 2016 May;18(5):346-53. doi: 10.1016/j.micinf.2015.12.009. Epub 2016 Jan 14.
3
Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.通过引导HIV-1包膜糖蛋白进入扰动敏感的非天然状态的因子,在多种二级分离株中诱导出类似一级的表型。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00174-17. Print 2017 Aug 1.
4
Neutralization tiers of HIV-1.HIV-1 的中和层级。
Curr Opin HIV AIDS. 2018 Mar;13(2):128-136. doi: 10.1097/COH.0000000000000442.
5
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.通过对包膜免疫原进行策略性选择实现针对2级HIV-1病毒的强效自体中和抗体反应。
J Immunol. 2016 Apr 1;196(7):3064-78. doi: 10.4049/jimmunol.1500527. Epub 2016 Mar 4.
6
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.通过初免-加强免疫在兔体内诱导异源2级HIV-1中和及交叉反应性V1/V2特异性抗体
J Virol. 2016 Sep 12;90(19):8644-60. doi: 10.1128/JVI.00853-16. Print 2016 Oct 1.
7
Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.优化和验证 A3R5 细胞中 HIV-1 的中和抗体检测方法。
J Immunol Methods. 2014 Jul;409:147-60. doi: 10.1016/j.jim.2014.02.013. Epub 2014 Mar 6.
8
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.针对具有传播奠基者Env的HIV-1细胞间传播的广谱中和抗体的效力降低及中和不完全
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02425-16. Print 2017 May 1.
9
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.从 HIV-1 分离物中和模式来描绘多克隆血清中的抗体识别。
Science. 2013 May 10;340(6133):751-6. doi: 10.1126/science.1233989.
10
Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.MW965包膜蛋白中调节原发性HIV-1分离株中和表型及构象屏蔽潜力的新型结构决定因素的鉴定。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01779-17. Print 2018 Mar 1.

引用本文的文献

1
Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.哌啶类 CD4 模拟化合物暴露 HIV-1 感染细胞的易损Env 表位,使其对 ADCC 敏感。
Viruses. 2023 May 17;15(5):1185. doi: 10.3390/v15051185.
2
HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier.HIV-1 发夹前中间体抑制剂的疗效不依赖中和作用。
Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2215792120. doi: 10.1073/pnas.2215792120. Epub 2023 Feb 16.
3
Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env.

本文引用的文献

1
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.通过超稳定化提高天然样 HIV-1 包膜三聚体的免疫原性。
Cell Rep. 2017 Aug 22;20(8):1805-1817. doi: 10.1016/j.celrep.2017.07.077.
2
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.降低可溶性、类天然HIV-1包膜糖蛋白三聚体上V3区的抗原性和免疫原性。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00677-17. Print 2017 Aug 1.
3
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
结构动力学揭示了HIV包膜糖蛋白(Env)中和表位上的毒株特异性差异。
iScience. 2022 May 23;25(6):104449. doi: 10.1016/j.isci.2022.104449. eCollection 2022 Jun 17.
4
A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.在感染早期的 HIV-1 中,一种中和抗体的靶标在接种了传播/原始包膜序列的恒河猴中得到了重现。
PLoS Pathog. 2022 May 3;18(5):e1010488. doi: 10.1371/journal.ppat.1010488. eCollection 2022 May.
5
Dual Role of HIV-1 Envelope Signal Peptide in Immune Evasion.HIV-1 包膜信号肽的双重免疫逃逸作用。
Viruses. 2022 Apr 13;14(4):808. doi: 10.3390/v14040808.
6
Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.导致对广泛中和抗体产生抗性的突变可定义来自于传播型母亲的 HIV-1 变体和非传播型母亲的 HIV-1 变体。
PLoS Pathog. 2021 Apr 2;17(4):e1009478. doi: 10.1371/journal.ppat.1009478. eCollection 2021 Apr.
7
Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection.广谱中和血浆抗体对多变异 HIV-1 感染婴儿体内自身循环病毒有效。
Nat Commun. 2020 Sep 2;11(1):4409. doi: 10.1038/s41467-020-18225-x.
8
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.数学建模揭示 HIV 抗体介导预防(AMP)试验中的突破性机制。
PLoS Comput Biol. 2020 Feb 21;16(2):e1007626. doi: 10.1371/journal.pcbi.1007626. eCollection 2020 Feb.
9
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.P2X1 选择性拮抗剂通过抑制包膜构象依赖性融合阻断 HIV-1 感染。
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01622-19.
10
Broadly Neutralizing Antibodies against HIV: Back to Blood.广谱中和抗体抗 HIV:回到血液。
Trends Mol Med. 2019 Mar;25(3):228-240. doi: 10.1016/j.molmed.2019.01.007. Epub 2019 Feb 18.
通过下一代中和指纹图谱绘制多克隆HIV-1抗体反应
PLoS Pathog. 2017 Jan 4;13(1):e1006148. doi: 10.1371/journal.ppat.1006148. eCollection 2017 Jan.
4
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.近期传播的HIV-1 C亚型病毒影响抗体识别的特征:对主动免疫和被动免疫的意义
PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul.
5
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.非中和表位暴露减少的稳定化HIV-1包膜三聚体的免疫原性
Cell. 2015 Dec 17;163(7):1702-15. doi: 10.1016/j.cell.2015.11.056.
6
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.两种增加天然样Env免疫原库的HIV-1 C亚型SOSIP.664三聚体的设计与结构
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11947-52. doi: 10.1073/pnas.1507793112. Epub 2015 Sep 8.
7
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.一种基于HIV-1 B亚型env基因的类天然SOSIP.664三聚体。
J Virol. 2015 Mar;89(6):3380-95. doi: 10.1128/JVI.03473-14. Epub 2015 Jan 14.
8
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.通过组合靶向主要中和表位的广泛反应性HIV-1抗体提高中和效力和广度。
J Virol. 2015 Mar;89(5):2659-71. doi: 10.1128/JVI.03136-14. Epub 2014 Dec 17.
9
Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.病毒分支、地理位置及流行时间对HIV-1抗体中和作用的影响。
J Virol. 2014 Nov;88(21):12623-43. doi: 10.1128/JVI.01705-14. Epub 2014 Aug 20.
10
Statistical approaches to analyzing HIV-1 neutralizing antibody assay data.分析HIV-1中和抗体检测数据的统计方法。
Stat Biopharm Res. 2012 Jan 1;4(1):1-13. doi: 10.1080/19466315.2011.633860.